Shimadzu Of Japan Develops New Alzheimer's Diagnosis Technique
This article was originally published in PharmAsia News
Executive Summary
Japan's Shimadzu says it has developed a way to diagnose miniscule amounts of amyloid beta protein believed to be a cause of Alzheimer's disease.